Geodon is manufactured by Pfizer, Inc.
Geodon belongs to a group of medications called atypical (or second-generation)
antipsychotic medications. It is not entirely known how it works for the treatment of schizophrenia or
bipolar disorder. However, it is known that the drug blocks or lessens the effects of several chemicals in the brain. These brain chemicals (such as dopamine and serotonin) may be elevated in people with schizophrenia or bipolar disorder (also known as
manic depression).
Effects of the Medication
In previous clinical studies of Geodon for the treatment of schizophrenia, people taking the medication experienced improvements in their schizophrenia symptoms (including hallucinations and suspiciousness), compared to those not taking it.
Longer studies also showed that the medication can help symptoms from returning.
Previous clinical studies have also shown it to be effective for
bipolar disorder treatment. In these studies, the drug was effective at treating episodes of mania or mixed episodes (which involve symptoms of both mania and
depression).